Traumatic brain injury and hemorrhagic stroke, mainly caused by car accidents, sports and cycling, cause increased pressure in the brain. This results in constricted blood vessels and limits blood flow and oxygen delivery to the brain. The lack of oxygen supply causes death of brain cells leading to disability or death of approximately 7.7 million people a year.
Inaccurate assessment increases risks
Lack of comprehensive methods for assessment of patient's condition increases risks associated with under and over-treatment.
Current treatments are limited
Systemic pharmacological intervention
Cerebrospinal fluid drainage (EVD) (introduced 1744)
Decompressive Craniectomy (opening the skull - introduced 1518)
SynCath Neuroscience is a preclinical stage MedTech startup, encapsulating assets of a groundbreaking research program, initiated and led by Prof Ofer Barnea and Dr Omer Doron. Our proprietary technology is based on an ECG-synchronized dynamic ICP-modulation. The technology is realized via a disposable, autonomous ICP modulation probe. The probe is in-dwelling, ECG-synchronized and delivered via an EVD (external ventricular drain) like catheter. The technology for the Syncath system was developed and validated at Tel-Aviv University and at Hadassah Medical Center.
By combining medicine with engineering, physics and mathematical modeling, they succeeded in creating breakthrough technology in neuro-critical care. SynCath holds an exclusive license on an elaborate IP portfolio.
EVD & ICP Monitoring markets – $2.8B & $1.9B in 2025, respectively with approx. 5% CAGR.
Conservative analysis yields a present global annual incidence of 1.1M patients that translate into an initial worldwide addressable market potential of $3B. SynCath is anticipated to launch its first release of the Syncath system in 2022 and subsequently launch other functions of this system.
Completed development of product prototype
Optimized the ECG-synchronization, pressure-stimulation waveform and intensity for the naïve porcine animal model
Setup and adapted two “gold standard” porcine disease animal models for TBI (traumatic brain injury)
Tested and optimized the therapeutic stimulation protocols in a large cohort of disease model pigs
Landmark paper in Journal of Neurosurgery: Doron O et al. "Cerebral blood flow augmentation using a cardiac-gated using an intracranial pulsating balloon pump in a swine model of elevated ICP
Developed and started design verification of the console and balloon catheter